This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.  Read our Cookies Policy.
Close
Eye News
  • Features
    • Close
    • Features
    • Allied Professions
    • Humanitarian
    • Interviews
    • AI & Oculomics
    • Ophthalmology
    • Optometry
    • Podcast videos
    • Supplements
  • Education
    • Close
    • Education
    • Learning Curve
    • Quiz
    • Top Tips
    • Trainees
    • Medico-Legal
    • The Truth Behind The Headlines
    • Case Reports
    • Pete's Bogus Journey
  • Reviews
    • Close
    • Reviews
    • Book Reviews
    • Journal Reviews
    • What's trending?
    • Tech Reviews
    • My Top Five
    • The Culture Section
  • Events
  • News
  • Product Guide
  • Industry News
  • Contact us
    • Close
    • Contact us
    • Write for Eye News
  • Home
  • Reviews
  • Journal Reviews
  • Atopic keratoconjunctivitis (AKC) and ocular surface squamous neoplasia (OSSN)

Atopic keratoconjunctivitis (AKC) and ocular surface squamous neoplasia (OSSN)
Reviewed by Yamini Krishna

1 April 2017 | Yamini Krishna | EYE - Pathology, EYE - Oncology | Atopia, Inflammation, Masquerade, Neoplasia, Ocular surface

The authors present two cases of invasive OSSN in patients with severe AKC. Case 1 was a 73-year-old male with severe AKC and atopic eczema who developed a suspicious papillary-like limbal lesion in the left eye. He had an excisional biopsy with cryotherapy and treated postoperatively with four cycles of topical mitomycin C. Histological assessment confirmed complete excision of a conjunctival intraepithelial neoplasia with severe dysplasia. Recurrences of the tumour in the left eye were treated with repeated cryotherapy, topical interferon α2b, followed by topical 5-fluorouracil but ultimately a lid-sparing exenteration was needed. Case 2 involved a 53-year-old male with severe AKC and atopic eczema who developed bilateral perilimbal lesions. The lesion in the right eye extended to the lids. Computerised tomography scan of the orbits revealed an extensive right orbital mass involving the extraocular muscles and lacrimal gland. The patient underwent a right orbitotomy with biopsies of the right orbital mass, lids and conjunctiva, and left conjunctiva. Histological diagnosis confirmed an invasive squamous cell carcinoma in the right eye and in situ in the left. The patient had a right exenteration and the left eye was treated topically with interferon α2b. Chronic inflammation associated with AKC is thought to be a risk factor for OSSN along with immunosuppression, human papillomavirus (HPV) and smoking. Both patients were on topical steroids with case 2 also being treated systemically. History of smoking or HPV status have not been mentioned. This study adds to a few other case reports suggesting an association of AKC and atopic eczema with OSSN. 

Ocular surface squamous neoplasia associated with atopic keratoconjunctivitis.
Shah A, Espana EM, Singh AD.
OCULAR ONCOLOGY AND PATHOLOGY
2017;3:22-7.
Share This
Yamini Krishna
CONTRIBUTOR
Yamini Krishna

Liverpool Ocular Oncology Research Group, University of Liverpool & Royal Liverpool University Hospital, Liverpool University Hospitals NHS Foundation Trust, Liverpool, UK.

View Full Profile
Specialty
  • EYE - Cataract
  • EYE - Cornea
  • EYE - General
  • EYE - Glaucoma
  • EYE - Neuro-ophthalmology
  • EYE - Oculoplastic
  • EYE - Oncology
  • EYE - Orbit
  • EYE - Paediatrics
  • EYE - Pathology
  • EYE - Refractive
  • EYE - Strabismus
  • EYE - Vitreo-Retinal
Archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013

Top Of Page

9 Gayfield Square, 
Edinburgh EH1 3NT, UK.

Call: +44 (0)131 557 4184
www.pinpoint-scotland.com

WEBSITE DETAILS
  • Cookie Policy
  • Data Protection Notice
  • Privacy Policy
  • Terms and Conditions
ABOUT US
  • Who we are
  • Register
  • Contact us
  • Contributors
  • Company Awards
DIGITAL ISSUES/GUIDELINES
  • Digital issues - Library
  • Supplements - Library
  • Guidelines
Accreditations
IPSO_FLAG_TEAL 2025.png cpdcertified.png

Pinpoint Scotland Ltd (Registered in Scotland No. SC068684) | © 2025 - Website by Gecko Agency